Dragon vein concept stock, take it without gratitude one 1177.HK (China Biopharmaceutical) is the most liquid target of the CP Group, and Xie Qirun, the daughter of Xie Bing, is currently the Chairman of the Board. 2. Hao Oubo（ 688656. SH will be included in the A-share market in 2024, marking the first time in history that a Hong Kong stock company has acquired an A-share market. 3. Zhengda Group holds significant equity stakes in both Ping An and CITIC Group.